The Aminoglycoside Antibiotic Gentamicin is Able to Alter Metabolic Activity and Morphology of MDCK-C11 Cells: a Cell Model of Intercalated Cells

Overview

Journal Braz J Med Biol Res

Specialties Biology
General Medicine

Date 2018 Aug 30

PMID 30156610

Authors

A G G Coutinho

S M P Biscaia

R Fernandez

A L Tararthuch

Affiliations

Soon will be listed here.

Abstract

It is well known that the aminoglycoside antibiotic gentamicin is capable of causing damage to kidney cells. Given the known involvement of Ca2+ in the nephrotoxic action of gentamicin, the purpose of this study was to establish a relationship between the concentration of intracellular Ca2+ ([Ca2+]i) and cellular cytotoxicity using MDCK-C11 cells, a clone that has several properties that resemble those of intercalated cells of the distal nephron. Changes in [Ca2+]i was determined using fluorescence microscopy. Cell viability was evaluated by the neutral red method, and cell cytotoxicity by the MTT method. The [Ca2+]i gradually increased when cells were exposed to 0.1 mM gentamicin for 10, 20, and 30 min. The presence of extracellular Ca2+ was found to be necessary to stimulate the increase in [Ca2+]i induced by gentamicin, since this stimulus disappeared by using 1.8 mM EGTA (a Ca2+ chelator). Morphological changes were observed with scanning electron microscopy in epithelial cells exposed to the antibiotic. Furthermore, with the MTT method, a decrease in metabolic activity induced by gentamicin was observed, which indicates a cytotoxic effect. In conclusion, gentamicin was able to alter [Ca2+]i, change the morphology of MDCK-C11 cells, and promote cytotoxicity.

References

Gibbons C, Maldonado-Perez D, Shah A, Riccardi D, Ward D . Calcium-sensing receptor antagonism or lithium treatment ameliorates aminoglycoside-induced cell death in renal epithelial cells. Biochim Biophys Acta. 2008; 1782(3):188-95. DOI: 10.1016/j.bbadis.2008.01.003. View

Myrdal S, Steyger P . TRPV1 regulators mediate gentamicin penetration of cultured kidney cells. Hear Res. 2005; 204(1-2):170-82. PMC: 2736064. DOI: 10.1016/j.heares.2005.02.005. View

Xu C, Bailly-Maitre B, Reed J . Endoplasmic reticulum stress: cell life and death decisions. J Clin Invest. 2005; 115(10):2656-64. PMC: 1236697. DOI: 10.1172/JCI26373. View

Ward D, Maldonado-Perez D, Hollins L, Riccardi D . Aminoglycosides induce acute cell signaling and chronic cell death in renal cells that express the calcium-sensing receptor. J Am Soc Nephrol. 2005; 16(5):1236-44. DOI: 10.1681/ASN.2004080631. View

Fernandez R, Oliveira-Souza M, Malnic G . Na+-independent proton secretion in MDCK-C11 cells. Pflugers Arch. 2001; 441(2-3):287-93. DOI: 10.1007/s004240000411. View

Leehey D, Braun B, Tholl D, Chung L, Gross C, Roback J . Can pharmacokinetic dosing decrease nephrotoxicity associated with aminoglycoside therapy. J Am Soc Nephrol. 1993; 4(1):81-90. DOI: 10.1681/ASN.V4181. View

Santucci R, Krieger J . Gentamicin for the practicing urologist: review of efficacy, single daily dosing and "switch" therapy. J Urol. 2000; 163(4):1076-84. DOI: 10.1016/s0022-5347(05)67697-5. View

Moestrup S, Cui S, Vorum H, Bregengard C, Bjorn S, Norris K . Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs. J Clin Invest. 1995; 96(3):1404-13. PMC: 185763. DOI: 10.1172/JCI118176. View

Reilly T, Bellevue 3rd F, Woster P, Svensson C . Comparison of the in vitro cytotoxicity of hydroxylamine metabolites of sulfamethoxazole and dapsone. Biochem Pharmacol. 1998; 55(6):803-10. DOI: 10.1016/s0006-2952(97)00547-9. View

10.

Quiros Y, Vicente-Vicente L, Morales A, Lopez-Novoa J, Lopez-Hernandez F . An integrative overview on the mechanisms underlying the renal tubular cytotoxicity of gentamicin. Toxicol Sci. 2010; 119(2):245-56. DOI: 10.1093/toxsci/kfq267. View

11.

Blankenship K, Williams J, Lawrence M, McLeish K, Dean W, Arthur J . The calcium-sensing receptor regulates calcium absorption in MDCK cells by inhibition of PMCA. Am J Physiol Renal Physiol. 2001; 280(5):F815-22. DOI: 10.1152/ajprenal.2001.280.5.F815. View

12.

Ward D, McLarnon S, Riccardi D . Aminoglycosides increase intracellular calcium levels and ERK activity in proximal tubular OK cells expressing the extracellular calcium-sensing receptor. J Am Soc Nephrol. 2002; 13(6):1481-9. DOI: 10.1097/01.asn.0000015623.73739.b8. View

13.

Randjelovic P, Veljkovic S, Stojiljkovic N, Sokolovic D, Ilic I . Gentamicin nephrotoxicity in animals: Current knowledge and future perspectives. EXCLI J. 2017; 16:388-399. PMC: 5427480. DOI: 10.17179/excli2017-165. View

14.

Nagai J, Takano M . Entry of aminoglycosides into renal tubular epithelial cells via endocytosis-dependent and endocytosis-independent pathways. Biochem Pharmacol. 2014; 90(4):331-7. DOI: 10.1016/j.bcp.2014.05.018. View

15.

Plow E, Haas T, Zhang L, Loftus J, Smith J . Ligand binding to integrins. J Biol Chem. 2000; 275(29):21785-8. DOI: 10.1074/jbc.R000003200. View

16.

Karasawa T, Wang Q, Fu Y, Cohen D, Steyger P . TRPV4 enhances the cellular uptake of aminoglycoside antibiotics. J Cell Sci. 2008; 121(Pt 17):2871-9. PMC: 2736053. DOI: 10.1242/jcs.023705. View

17.

Balakumar P, Rohilla A, Thangathirupathi A . Gentamicin-induced nephrotoxicity: Do we have a promising therapeutic approach to blunt it?. Pharmacol Res. 2010; 62(3):179-86. DOI: 10.1016/j.phrs.2010.04.004. View

18.

Mosmann T . Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983; 65(1-2):55-63. DOI: 10.1016/0022-1759(83)90303-4. View

19.

Gekle M, Wunsch S, Oberleithner H, Silbernagl S . Characterization of two MDCK-cell subtypes as a model system to study principal cell and intercalated cell properties. Pflugers Arch. 1994; 428(2):157-62. DOI: 10.1007/BF00374853. View

20.

Woods A, Couchman J . Integrin modulation by lateral association. J Biol Chem. 2000; 275(32):24233-6. DOI: 10.1074/jbc.R000001200. View